Fundraising Fox
Cathy Friedman
InvestorExecutive Venture Partner at GV (Google Ventures) · Board director at Pelage
United States
Writes $250K – $50M checks · typically $25M
Find your path to Cathy
977 people in our graph can introduce you to Cathy.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Anika Gupta to introduce you to Cathy
You →Anika · together at GV (Google Ventures) →Cathy
Ask Jamie Chen to introduce you to Cathy
You →Jamie · 11 people · together at GV (Google Ventures) →Cathy
Sign up to find every way you can get introduced to Cathy
- Your email: the people you already email who know Cathy
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Cathy
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Cathy Friedman is an Executive Venture Partner at GV with nearly 40 years of experience across banking, technology, and life sciences. She previously spent nearly 24 years at Morgan Stanley, where she was a managing director and co-head of the biotech practice, and later worked as an independent financial consultant and board member. At GV she is a senior member of the investing team and advises the firm's life sciences portfolio alongside Dan Lynch.
Likely email· guessed from name + firm domain, not firm-published
- c•••@gv.comreveal100% confident
Invests in
BiotechDigital HealthFemTechHealthtech
Board director at Pelage
Intro paths
In turn, Cathy can intro founders to Pelage's investors below.
Pelage's investors · 5
Co-founders at Pelage
Experience
- GVExecutive Venture Partner GVcurrent2022 — presentSan Francisco Bay Area
- Lyell ImmunopharmaBoard Membercurrent2018 — presentSouth San Francisco, California
- Altaba.comBoard Member2016 — 2026New York, New York
- Revolution Health Acquisition CorpBoard Member2021 — 2022United States
- GRAIL, Inc.Chairperson2017 — 2022Menlo Park, California
- Radius Health, Inc.Board Member2015 — 2021Waltham, Massachusetts
- Morgan StanleyManaging Director1982 — 2006New York, London, San Francisco, Silicon Valley
Investments
Board seats
AltabaGrailLyell ImmunopharmaRadius HealthRevolution Healthcare Acquisition CorpSeerVividion Therapeutics
Per the firm's website.
Colleagues at GV (Google Ventures)
Network9
Investors connected to Cathy in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Cathy Friedman?
- Cathy Friedman is an Executive Venture Partner at GV with nearly 40 years of experience across banking, technology, and life sciences. She previously spent nearly 24 years at Morgan Stanley, where she was a managing director and co-head of the biotech practice, and later worked as an independent financial consultant and board member. At GV she is a senior member of the investing team and advises the firm's life sciences portfolio alongside Dan Lynch.
- Where does Cathy Friedman work?
- Cathy Friedman is Executive Venture Partner at GV (Google Ventures) and Board director at Pelage.
- What does Cathy Friedman invest in?
- Cathy Friedman invests in Biotech, Digital Health, FemTech, Healthtech.
- What check size does Cathy Friedman write?
- Cathy Friedman typically writes checks of $250K – $50M.
- What boards does Cathy Friedman sit on?
- Cathy Friedman holds tracked board seats at Altaba, Grail, Lyell Immunopharma, Radius Health, Revolution Healthcare Acquisition Corp, Seer, Vividion Therapeutics.
- Where did Cathy Friedman go to school?
- Cathy Friedman studied at University of Virginia Darden School of Business (Master of Business Administration - MBA); Harvard University (AB, Economics).
Same school
Also attended University of Virginia Darden School of Business238
+ 232 more
Also attended Harvard University2,000
+ 1,994 more
Shared employers
Also worked at Lyell Immunopharma10
+ 4 more
Also worked at GRAIL, Inc.22
+ 16 more
Also worked at Radius Health, Inc.5
Also worked at Morgan Stanley1,735
+ 1,729 more